arrow
G

Gemma Moncunill

isglobal
H指数:35
被引数:4,397

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Limited impact of ivermectin on immune response and transcriptional profiles in mild COVID-19

伊维菌素对轻度COVID-19免疫反应和转录组谱的有限影响

2026-10-010
OAAI
Comparative C1q- and FcγR-binding antibody profiles and immunoglobulin type signatures after Omicron XBB-adapted PHH-1V81 and BNT162b2 COVID-19 boosters

比较奥密克戎XBB适配的PHH-1V81和BNT162b2 COVID-19加强针后的C1q和FcγR结合抗体谱及免疫球蛋白类型特征

2026-09-220
OAAI
Primary SARS-CoV-2 exposure by vaccination or infection shapes immune responses to omicron variants among a Spanish cohort

通过疫苗接种或感染导致的初次SARS-CoV-2暴露,塑造了西班牙队列对omicron变异株的免疫应答。

2025-12-130
OAAI
VEGFA sex-specific signature is associated to long COVID symptom persistence

VEGFA的性别特异性特征与长新冠症状的持续存在相关

2025-10-120
OAAI
Prepandemic levels of cytokines and immunoglobulins and risk of SARS-CoV-2 infection and COVID-19 in the general population of Barcelona

大流行前细胞因子和免疫球蛋白水平与巴塞罗那一般人群SARS-CoV-2感染及COVID-19的风险

2025-08-240
OA
Early-life exposome and health-related immune signatures in childhood

生命早期暴露组与儿童健康相关的免疫特征

2025-07-050
OA
Role of malaria exposure and off-target responses on RTS,S/AS02A vaccine immunogenicity and protection in Mozambican children

疟疾暴露及脱靶反应对RTS,S/AS02A疫苗免疫原性和保护作用的影响:以莫桑比克儿童为例

2025-06-060
OAAI
Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic

大流行开始三年后对SARS-CoV-2的长期抗体B细胞应答

2025-04-010
OAAI
Risk, determinants, and persistence of long-COVID in a population-based cohort study in Catalonia

长期COVID的风险、决定因素及其在加泰罗尼亚一项基于人群的队列研究中的持续性

2025-03-140
OA
Malaria and other infections induce polyreactive antibodies that impact SARS-CoV-2 seropositivity estimations in endemic settings
2024-06-140
OAAI
Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccination
2024-03-087
OAAI